AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\n\nFor each recommendation, specify:\n1. The type of recommendation:\n   - Additional information needed (history/examination/investigations)\n   - Improved patient advice (options/statistics/patient information)\n   - Different management plan\n2. The specific recommendation\n3. The reason for the recommendation (referencing the guideline)\n\nCategorize each recommendation by importance:\n- Very Important: Critical for patient safety or guideline compliance\n- Somewhat Important: Significant for optimal care but not critical\n- Less Important: Would improve care but not essential\n- Unimportant: Minor suggestions that could be considered\n\nFormat the response as follows:\n\n### Very Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Somewhat Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Less Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Unimportant Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\nClinical Note:\nSITUATION: 28-year-old G1P1 presenting with acute onset premature rupture of membranes (prom)\n\nBACKGROUND: Patient has a background of [relevant medical history]. Current pregnancy/cycle has been uncomplicated until now. No known drug allergies. Regular medications include folic acid 5mg daily. Family history significant for maternal diabetes and hypertension.\n\nASSESSMENT: On examination: BP 140/90, HR 88, temp 37.2°C. Abdomen soft, fundal height appropriate. CTG shows baseline 140 with good variability. Urinalysis shows trace protein. Bloods pending including FBC, U&Es, LFTs, and coagulation studies.\n\nRECOMMENDATION: Plan: Admit for monitoring and further investigation. IV access established. Continuous CTG monitoring. Serial BP measurements. Consultant review within 2 hours. Consider delivery if condition deteriorates.\n\nADDITIONAL NOTES:\n- Patient counselled regarding condition and management options\n- Written information provided\n- Next of kin contacted and updated\n- Documentation completed in patient notes\n- Handover given to on-call team\n\nPLAN:\n- Continuous monitoring as per protocol\n- Serial observations 4-hourly\n- Repeat bloods in 24 hours\n- Consultant review tomorrow morning\n- Discharge planning when appropriate\n\nSigned: Dr. [Name]\nDate: [Current date]\nTime: [Current time]\n\nGuideline:\n[ID] bjog-2019-thomson-care-of-women-presenting-with-suspected-preterm-prelabour-rupture-of-membranes-from-24-0-weeks-of-pdf\nTitle: BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf\nContent: Key Recommendations:\n- Diagnosis of spontaneous rupture of membranes made by maternal history followed by sterile speculum examination\n- Consider IGFBP-1 or PAMG-1 test if no amniotic fluid observed on speculum examination\n- Antibiotic (preferably erythromycin) given for 10 days or until established labor in PPROM\n- Offer corticosteroids to women with PPROM between 24+0 and 33+6 weeks gestation\n- Use clinical assessment, maternal blood tests, and fetal heart rate to diagnose chorioamnionitis\n- Offer expectant management until 37+0 weeks in women with no contraindications to continuing pregnancy\n- Offer intravenous magnesium sulfate to women with PPROM in established labor between 24+0 and 29+6 weeks gestation\n\nBackground:\n- PPROM complicates up to 3% of pregnancies and is associated with 30-40% of preterm births\n- Median latency after PPROM is 7 days and shortens with advancing gestational age\n\nDiagnosis:\n- Diagnosis made by maternal history and sterile speculum examination\n- Consider IGFBP-1 or PAMG-1 test if no amniotic fluid observed\n- Ultrasound for amniotic fluid volume unclear\n- Testing for nitrazine not recommended\n- Routine vaginal swab for microbiological testing\n\nAssessment:\n- Use clinical assessment, maternal blood tests, and fetal heart rate to diagnose chorioamnionitis\n- Women advised and observed for symptoms of chorioamnionitis\n- White cell count and C-reactive protein used to identify infection\n- Vital signs recorded for inpatients, regular monitoring for outpatients\n\nInvolvement of Neonatologists:\n- Neonatologists informed when PPROM diagnosis confirmed and delivery anticipated\n- Women offered opportunity to meet with neonatologist antenatally\n\nManagement:\n- Erythromycin given for 10 days following PPROM diagnosis\n- Antenatal corticosteroids offered from 24+0 to 35+6 weeks gestation\n- Consideration of individual basis for administration due to potential side effects\n\nNG25 recommends that corticosteroids should be considered between 24+0 and 25+6 weeks’ gestation. Corticosteroids should be offered from at least 24+0 weeks’ gestation. In women with PPROM and planned preterm birth within 24 hours, magnesium sulfate should be offered between 24+0 and 29+6 weeks of gestation. Tocolysis is not recommended for patients with PPROM. Outpatient care for women with PPROM should be considered on an individual basis. Amnioinfusion is not recommended as routine practice for PPROM. Emotional support should be offered to women with PPROM and their partners. Expectant management until 37+0 weeks should be offered to women with PPROM after 24+0 weeks’ gestation. In subsequent pregnancies following PPROM, women should be cared for by an obstetrician with an interest in preterm birth. Further research is needed on various aspects of PPROM management. Auditable topics include offering antibiotics, corticosteroids, magnesium sulfate, and discussions with a neonatologist to women with PPROM.\n\nGynaecologists\nUseful links and support groups:\n- Royal College of Obstetricians and Gynaecologists. When your waters break early. Information for you. London: RCOG; 2019.\n- Little Heartbeats, a support group that promotes the awareness of PPROM [www.little-heartbeats.org.uk].\nAcknowledgments:\nThe RCOG would like to thank Dr Sarah Prince for her assistance in developing the new Green-top Guideline format.\n\nMiss S JhaMD, FRCOG, Shefﬁeld Teaching Hospitals NHS Foundation Trust, Shefﬁeld; A Pickersgill FRCOG, Manchester University NHS Foundation Trust, Manchester; L Thomas, RCOG, Epsom; Professor JE Norman, University of Edinburgh, Edinburgh; M Costantine, MD, The University of Texas Medical Branch, Houston, TX, USA; V Phupong FRTCOG, Chulalongkorn University, Bangkok; Dr NA Khan, Al Qassmiya Women’s and Child Hospital, Sharjah, United Arab Emirates; UK National Screening Committee Evidence Team; G Kumar FRCOG, Wrexham Maelor Hospital, Wrexham; D Fraser FRCOG, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich; S Roy MA MRCS MRCP, Cambridge University Hospitals NHSFT, Cambridge; Little Heartbeats; H Eadon, BPharm MSc MRPharmS, National Guideline Alliance, London; Harris Wellbeing Preterm Birth Centre; J Girling, Chelsea and Westminster Hospital NHS Foundation Trust, London; EF Magann FACOG, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Birth Trauma Association; PS Yeh MRCOG, London North West University Healthcare NHS Trust, London; RCOG Women’s Network; Professor DOC Anumba, MBBS FWACS FRCOG MD LL.M (Medical Law), The University of Shefﬁeld, Shefﬁeld; L Chappell, King’s College London, London; H Mactier, Honorary Secretary of the British Association of Perinatal Medicine, Glasgow.\n\nCommittee lead reviewers were: Dr B Kumar FRCOG, Wrexham and Dr B Magowan FRCOG, Melrose. The chair of the Guidelines Committee were: Dr MA Ledingham FRCOG, Glasgow; Dr B Magowan FRCOG, Melrose; and Dr AM Thomson MRCOG, Paisley. All RCOG guidance developers are asked to declare any conﬂicts of interest. The ﬁnal version is the responsibility of the Guidelines Committee of the RCOG. The guideline will be considered for update 3 years after publication, with an intermediate assessment of the need to update 2 years after publication.",
  "system_prompt": "You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.",
  "guideline_id": "bjog-2019-thomson-care-of-women-presenting-with-suspected-preterm-prelabour-rupture-of-membranes-from-24-0-weeks-of-pdf",
  "guideline_title": "BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf"
}

A: Here is the analysis of the clinical note against the provided guideline, with recommendations for improvement:

### Very Important Recommendations
1. **Additional information needed** - Document whether a sterile speculum examination was performed to confirm PPROM diagnosis.  
   Reason: Guideline states diagnosis should be made by maternal history followed by sterile speculum examination.  

2. **Different management plan** - Initiate erythromycin for 10 days or until established labor.  
   Reason: Guideline recommends antibiotic (preferably erythromycin) given for 10 days or until established labor in PPROM.  

3. **Different management plan** - Offer corticosteroids if gestation is between 24+0 and 33+6 weeks.  
   Reason: Guideline recommends offering corticosteroids to women with PPROM between 24+0 and 33+6 weeks gestation.  

4. **Additional information needed** - Document gestational age explicitly in the note.  
   Reason: Many recommendations (e.g., corticosteroids, magnesium sulfate) depend on gestational age, which is not clearly stated.  

### Somewhat Important Recommendations
1. **Improved patient advice** - Offer emotional support and provide links to support groups (e.g., Little Heartbeats).  
   Reason: Guideline recommends emotional support should be offered to women with PPROM and their partners.  

2. **Additional information needed** - Document discussion with neonatology team if delivery is anticipated.  
   Reason: Guideline states neonatologists should be informed when PPROM diagnosis is confirmed and delivery is anticipated.  

3. **Different management plan** - Consider magnesium sulfate if delivery is planned within 24 hours and gestation is 24+0 to 29+6 weeks.  
   Reason: Guideline recommends magnesium sulfate for women with PPROM in established labor between 24+0 and 29+6 weeks.  

### Less Important Recommendations
1. **Additional information needed** - Document whether IGFBP-1 or PAMG-1 testing was considered if no amniotic fluid was observed.  
   Reason: Guideline suggests considering these tests if no amniotic fluid is seen on speculum exam.  

2. **Improved patient advice** - Provide written information about PPROM (e.g., RCOG patient leaflet).  
   Reason: Guideline references patient information resources, though the note already mentions "written information provided."  

### Unimportant Recommendations
1. **Additional information needed** - Consider documenting whether outpatient management was discussed.  
   Reason: Guideline suggests outpatient care can be considered on an individual basis, but inpatient monitoring is reasonable.  

2. **Improved patient advice** - Document whether the patient was counseled about the median latency period (7 days).  
   Reason: Guideline provides background statistics, but this is not critical for immediate management.  

### Summary of Critical Gaps:
- Absence of documented speculum exam (key for diagnosis).  
- Missing antibiotic (erythromycin) and corticosteroid administration if indicated.  
- Gestational age not explicitly stated, affecting multiple management decisions.  

These changes would significantly improve adherence to the guideline.

--- Token Usage Report ---
Prompt tokens: 1852
Completion tokens: 631
Total tokens: 2483
Estimated cost: $0.001241